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1. Introduction 
Calcium orthophosphates are subject to intensive investigations owing to their biological 
importance. The ion-substituted non-stoichiometric nano-sized poorly crystalline calcium 
orthophosphates, mainly with apatite structure, build the inorganic component of hard 
tissues in the organisms. The main ion substitutes are the ions Na+, K+, Mg2+, Fe2+, Zn2+, Si2+, 
CO32-, Cl-, and F- (Dorozhkin, 2009; Daculsi et al., 1997) and they differ in variety and 
amount depending on the type of the hard tissue, its age as well as on individual 
peculiarities. The so called “biological apatite” is formed in the living organisms as a result 
of biomineralization processes, the mechanism of which is not yet clarified. These processes 
include precipitation, dissolution and growth of poorly-crystalline calcium orthophosphates 
taking place in the organic matrix, e.g., collagen in the case of bones (Dorozhkin, 2009; 
Palmer et al., 2008) or amelogenin in the case of enamel (Palmer et al., 2008), in the presence 
of body fluids. One of the ways to elucidate the elementary processes occurring during bone 
hard tissue mineralization is the biomimetic approach designed to study these processes. 
The knowledge of the elementary processes is crucial for the development of new bioactive 
calcium phosphate materials (close to the natural ones) that may be applied for bone 
repairing, reconstruction and remodeling.  
The aim of this chapter is to throw light on the biomimetic precipitation and modification of 
calcium orthophosphates, XRD-amorphous calcium phosphate (ACP) and dicalcium 
phosphate dihydrate (DCPD) on the basis of authors’ kinetic, spectral (XRD and IR) and 
thermodynamic studies and literature data.  
2. Calcium orthophosphates – short review 
2.1 Classification 
Eleven calcium orthophosphates are known in the literature. According to the methods of 
their preparation they are divided into two groups - calcium phosphates precipitates and 
calcium phosphates calcinates (Table 1). The preparation of calcium phosphates precipitates 
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strongly depends on pH of the medium; that of calcium phosphates calcinates is a function 
of the calcination temperature. 
 
Abbreviation Chemical formula Ca/P 
Preparation 
conditions 
PRECIPITATES pH 
MCPM Ca(H2PO4)2.H2O 0.5 0 - 2 
MCPA Ca(H2PO4)2 0.5  
DCPD Ca(HPO4)2.2H2O 1.0 2 - 6 
DCPA Ca(HPO4)2 1.0  
OCP Ca8(PO4)4(HPO4)2.5H2O 1.33 5.5 - 7 
ACP Ca9(PO4)6.nH2O 1.5 5 - 12 
PCA Ca10-xx(PO4)6-x(HPO4)x.((OH)2-xx) 1.33-1.67 6.5 - 9.5 
HA Ca10(PO4)6(OH)2 1.67 9.5 - 12 
CALCINATES T,oC 
TCP 
-Ca3(PO4)2 1.5 >800 
-Ca3(PO4)2 1.5 >1125 
ТТCP Ca4(PO4)2Ǽ 2.0 >1500 
a  the table was adapted according to Dorozhkin (2009), Chow and Eanes (2001) and Johnsson and 
Nancollas (1992). 
Table 1. Calcium orthophosphatesa. 
2.2 Structures 
Calcium phosphates are divided into three groups according to their structure (Chow & 
Eanes, 2001): (i) Ca-PO4 sheet-containing compounds (MCPA, MCPM, DCPA DCPD). 
DCPD has a monoclinic structure, space group Ia , where HPO42- ions are linked to Ca2+ ions 
forming linear chains, that are stacked and form corrugated sheets parallel to the (010) face. 
The water molecules are situated between the sheets, bonded to the Ca2+ ion. The packing of 
the Ca-HPO4 ions in chains or sheets determine several possible pseudohexagonal 
arrangements, similar to the glaserite type structure (Curry & Jones, 1971; Dickens et al., 
1972; Dickens & Bowen, 1971); (ii) glaserite type compounds (-TCP and -TCP). Two types 
of columns along the c-axis in a pseudohexagonal arrangement, one containing only Ca2+ 
and other both Ca2+ and PO43- ions in a ratio 1:2 build the glaserite type structure of 
monoclinic -TCP (Mathew et al., 1977). In rhombohedral -TCP structure two types of 
columns contain both Ca2+ and PO43- ions (Dickens et al., 1974). One of the columns has 
vacancies at both cationic and anionic position; and (iii) apatite type compounds (OCP, 
TTCP, PCA and HA) (Chow & Eanes 2001; Mathai&Takagi, 2001). Commonly, HA has a 
hexagonal structure (space group P63/m) (Kay et al., 1964), where Ca2+ ions occupy two 
different crystallographic symmetry sites. Ca1 are located in columns along the c-axis, 
where is coordinated to nine O atoms. The Ca-O9 polyhedra are connected in chains parallel 
to c-axis. Ca2 are arranged in two triangular units. The Ca2 ions are 7-coordinated, with six 
O atoms and one OH- ion. Ca1 and Ca2 polyhedra are linked through oxygen atoms of the 
PO43- tetrahedra. Each OH- ion occupies statistically disordered positions. 
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OCP has a triclinic structure, which can be described as alternating along (100) “hydrated” 
and apatitic layers (Mathew et al., 1988). The atomic positions of the structure of OCP are 
very close to HA structure, which is the precondition for possible epitaxial growth and 
formation of interlayered structures, important for explanation of the process of 
biomineralization.  
A special position holds the amorphous calcium phosphate (ACP) which structure is built of 
Ca9(PO4)6, so called Posner’s clusters, where Ca2+ and PO43- ions are arranged in a hexagonal 
dense packing (Betts et al., 1975; Blumenthal et al., 1977).  
The existing symmetry relations between these structures ensure the easier phase 
transformations.  
2.3 Solubility 
Calcium orthophosphates are sparingly soluble in water (Table 2). HA has the lowest 
solubility among them, which is its natural priority. The solubility of calcium phosphates 
strongly depends on pH of the medium and this feature is of significance for their 
preparation and biological behavior. Thus, the practically insoluble mono-phase bio-
ceramics of dense HA do not actively participate in the process of bone remodeling (Tas, 
2004). However, upon contact with body fluids they participate in the formation of a surface 
layer of bone-like apatite. Mono-phase ǂ-TCP and ǃ-TCP display higher solubilities and 
rapidly degrade in vitro and in vivo (Radin & Ducheyne, 1993, 1994). Mg- and Zn-doped TCP 
ceramics display lower solubility than pure TCP ceramics and thus reduce the resorption 
rate (Xue, 2008). Bi-phase mixtures of HA and ǃ-TCP ceramics were developed in order to 
improve the biological behaviour of the mono-phase materials (Petrov et al., 2001; Teixeira 
et al., 2006).  
The knowledge on the Ca2+, H+/ OH-, PO43-//H2O system and its sub-systems may be used 
as a theoretical base for predetermination or optimization of the conditions for the 
preparation of different calcium orthophosphates. Unfortunately, owing to the low 
solubility and narrow crystallization fields of the different stable and metastable salts, there 
are no systematic experimental studies of this system. Only single solubility data are 
available for the binary sub-system Ca2+/PO43-//H2O at 25oC (Kirgintzev et al., 1972). More 
detailed studies were performed on the three-component Ca2+, H+/ PO43-//H2O sub-system 
and experimental data are available for the temperature range 0 – 100oC (Flatt et al., 1961; 
Bassett, 1958; Flatt et al., 1956; Chepelevskii et al., 1955; Belopol’skii, 1940; Bassett, 1917). 
Two hydrous and two anhydrous salts, namely Ca(H2PO4)2, Ca(H2PO4)2.H2O, CaHPO4 and 
CaHPO4.2H2O are established at 25oC and 40oC respectively; there are contradictions about 
the existence and stability of the salt of lowest solubility CaHPO4.2H2O (Bassett, 1917; 
Belopolskii et al., 1940; Chepelevskii et al., 1955). The solubility of Ca(H2PO4)2 and 
Ca(H2PO4)2.H2O slightly increases at temperatures above 50oC but CaHPO4.2H2O was not 
detected (Bassett, 1917; Chepelevskii et al., 1955).  
The most appropriate method for evaluation of the solubility of sparingly soluble calcium 
phosphate salts is the thermodynamic modeling. The ion association model based on the 
extended Debye-Huckel theory was applied to the Ca2+, H+/ OH-, PO43-//H2O system 
(Chow & Eanes, 2001; Johnnson & Nancollas, 1992). Thermodynamic data for the solubility 
products (lgKsp0) of all calcium orthophosphates and the complex formation constants (lgK0) 
of all complex species which may exist in aqueous calcium phosphate solutions are 
necessary for its application (Table 2). The calculations of Chow and Eanes (2001) have 
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shown that DCPA is the least soluble salt in the Ca2+, H+/ OH-, PO43-//H2O system at pH < 
4.2 and 25oC while HA becomes the least soluble salt at pH > 4.2; TTCP is the most soluble 
salt at pH <8.2 while DCPD is the most soluble salt at pH > 8.2. In the pH region 7.3 - 7.4 
typical for body fluids, the solubility of the salts at 25oC (Chow & Eanes, 2001) and 37oC 
(Johnnson & Nancollas, 1992) follows the order: 
TTCP > -TCP > DCPD > DCPA >OCP ~ -TCP > HA 
Chemical formula 
Solubility, g/l, 25oC 
(Dorozhkin, 2009) -lgKsp
0 
Ca(H2PO4)2.H2O ~18 1.14 (Fernandez et al., 1999) 
Ca(H2PO4)2 ~17 1.14 (Fernandez et al., 1999) 
CaHPO4.2H2O ~0.088 6.59 (Gregory et al., 1970) 
CaHPO4 ~0.048 6.90 (McDowell et al., 1971) 
Ca8H2(PO4)6.5H2O ~0.0081 96.6 (Tung et al., 1988) 
Ca3(PO4)2(am) - 25.2 (Meyer & Eanes 1978) 
Ca5(PO4)3Ǽǻ ~0.0003 58.4 (McDowell et al., 1977) 
-Ca3(PO4)2 ~0.0025 25.5 (Fowler & Kuroda, 1986) 
-Ca3(PO4)2 ~0.0025 28.9 (Gregory et al., 1974) 
Ca4(PO4)2Ǽ ~0.0007 38.0 (Matsuya et al., 1996) 
Complex formation constants 
(National Institute of Standards and Technology [NIST], 2003) 
H+ + H2PO4-=H3PO40 2.148 
H+ + HPO42-=H2PO4- 7.198 
H+ + PO43- = HPO42- 12.37 
Ca2++OH-=CaOH+ 1.303 
Ca2++ HPO42-=CaHPO40 2.66 
Ca2++ H2PO4-=CaH2PO4+ 1.35 
Ca2++ PO43-= CaPO4- 6.46 
Table 2. Solubility and thermodynamic data of the Ca2+, H+/ OH-, PO43-//H2O system. 
3. Electrolyte systems for biomimetic studies  
Electrolyte solutions of different composition, designed to mimic the аcellular human body 
plasma, have become a modern way to test bone-bonding abilities of bioactive materials or 
to produce thin calcium-phosphate layers on materials (metals, alloys or glasses) for bone 
graft substitutes (Yang & Ong, 2005; Raghuvir et al., 2006; Jalota et al., 2006; Kontonasaki et 
al., 2002). The composition of the most popular ones is presented in Table 3.  
Earle's balanced salt solution (EBSS, Ca/P = 1.8, HCO3- - 26.2mmol.dm-3) (Earle et al., 1943) 
and Hank’s balanced salt solution (HBSS, Ca/P = 1.6, HCO3- - 4.2mmol.dm-3) (Hanks & 
Wallace, 1949) were among the first simulated body solutions. Kokubo (1990) was the first to 
popularize a multicomponent inorganic solution, called conventional simulated body fluid 
(SBFc) which contains definite amounts of Na+, K+, Mg2+, Ca2+, Cl-, HCO32-, HPO42- and SO42- 
ions, has a Ca/P ratio of 2.5 (equal to that in the blood plasma), HCO3- concentration of 4.2 
mmol.dm-3 and physiologic pH of 7.3-7.4. To mimic the blood plasma in terms of the most 
important HCO3- ions, Bayractar and Tas (1999) revised the SBFc by increasing HCO3- 
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concentration up to 27 mmol.dm-3 at the account of Cl- ions (revised simulated body fluid, 
SBFr). The concentrations of Ca2+ and Mg2+ ions in the ionic SBF (SBFi) correspond to those 
of free Ca2+ and Mg2+ ions (not bound to proteins), in the blood plasma (Oyane, et al., 2003). 
 
Ion 
content 
Blood 
Plasma 
 
EBSS 
(Earle, et 
al., 1943) 
HBSS 
(Hanks 
and 
Wallace, 
1949) 
SBFc 
(Kokubo, 
1990) 
SBFr 
(Bayraktar 
and Tas, 
1999) 
SBFi 
(Oyane, et 
al., 2003) 
SBFg 
(this 
study) 
Na+ 142.0 143.5 142.1 142.0 142.0 142.0 142.0 
K+ 5.0 5.4 5.3 5.0 5.0 5.0 5.0 
Ca2+ 2.5 1.8 1.26 2.5 2.5 1.6 2.5 
Mg2+ 1.5 0.8 0.9 1.5 1.5 1.0 1.5 
Cl- 103.0 123.5 146.8 147.8 125.0 103.0 147.8 
HCO32- 27.0 26.2 4.2 4.2 27.0 27.0 4.2 
HPO42- 1.0 1.0 0.78 1.0 1.0 1.0 1.0 
Glycine - - - - - - 135.0 
SO42- 0.5 0.8 0.41 0.5 0.5 1.5 0.5 
Ca/P 2.5 1.8 1.62 2.5 2.5 1.6 2.5 
pH 7.4 7.2-7.6 6.7–6.9 7.2-7.4 7.4 7.4 7.3 
Table 3. Electrolyte solutions for in vitro experiments, mmol.dm-3. 
These solutions were buffered to the pH of blood plasma with TRIS, BITRIS or HEPES 
buffers.  
SBF modified with glycine (SBFg), essential for the biological system amino acid, was 
prepared on the basis of conventional SBF. Concentration of glycine was thermodynamically 
calculated so that the contents of free Ca2+ and Mg2+ ions to be analogous to SBFi. 
4. Biomimetic precipitation of ion modified precursors 
The biomimetic approach which includes precipitation processes of bioactive calcium 
phosphates in electrolyte medium of simulated body fluids and uses the influence of the 
medium composition on their formation and phase transformation have attracted extensive 
research interest (Xiaobo et al., 2009; Hui et al., 2009; Shibli & Jayalekshmi, 2009; Martin et 
al., 2009), because of their analogy to the biological mineralization processes. In the 
following, the authors’ studies on the precipitation of ion-modified ACP and DCPD 
precursors are summarized. 
Various crystal chemical and kinetic factors affect the crystallization process. The ion-modified 
calcium phosphates are mixed crystals (non-stoichiometric compounds), where  part of the 
ions building the crystal unit cell are substituted by other ions. The ability of the admixture ion 
to adopt the coordination of the substituted ion determines the substitution degree. 
To enable ion modification of calcium phosphate precursors with Na+, K+, Mg2+ and Cl- ions 
we have performed all our studies using conventional SBFc that was modified for each 
concrete case. Modified calcium-free simulated body fluid (SBFc-Cam) was used as a solvent 
for K2HPO4 (Solution 1) and phosphorus-free simulated body fluid (SBFc-Pm) was used as a 
solvent for CaCl2 (Solutions 2 and 5), for CaCl2 and MgCl2 (Solution 3) and for ZnCl2 
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(Solution 4) (Table 4). In this way preliminary precipitation was avoided. pH of the mixed 
solutions was adjusted to 7.2-7.4 using 0.1M HCl or 0.05M 2-amino-2-hydroxymethil-1,3-
propandiol.  
 
Ion 
content 
SBFc-Cam 
(Solution 1) 
SBFc-Pm 
*(Solution 2) 
SBFc-Pm 
(Solution 3) 
SBFc-Pm 
(Solution 4) 
SBFc-Pm 
**(Solution 5) 
Na+ 141.9 141.9 141.9 141.9 141.9 
K+ 506.4 3.0 3.0 3.0 5.0 
Mg2+ 1.5 1.5 1.5 1.5 1.5 
Ca2+ - 418.9 - x 418.9 - x  252.1 
Me2+ -  x x  
Cl- 142.8 975.6 -2x 975.6 142.8+2x 642.0 
SO42- 0.5 0.5 0.5 0.5 0.5 
HCO3- 4.2 4.2 4.2 4.2 4.2 
HPO42- 251.7 - - - 0.00 
* - in the case of ACP precipitation; ** - in the case of DCPD precipitation;  
     0< x < 83.8 mmol.dm-3. 
Table 4. Modified simulated body fluids (SBFs) (mmol.dm-3) used by the authors. 
The electrolyte medium provided by SBF plays a crucial role in the precipitation processes 
and influences the composition of the precipitated product. Precipitation, co-precipitation, 
ion substitution and ion incorporation reactions simultaneously take place. The cationic and 
anionic substitutions are mainly responsible for the calcium deficiency of the precipitated 
ACP precursors. Two methods – fast mixing or continuous co-precipitation of the reagents 
were applied in these studies. The method of precipitation affected the size, morphology 
and chemical homogeneity of the precipitate. 
SBF-modified XRD-amorphous calcium-deficient phosphate (ACP) (Fig. 1) with a Ca/P 
ratio of 1.3 or 1.51 (Table 5) due to ion substitution and incorporation of Na+, K+, Mg2+ and 
Cl- ions from the SBFs at levels close to those of natural enamel, dentin and bone 
(Dorozhkin, 2009), was precipitated. 
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2-theta-Scale
  
4000 3000 1500 1000 500
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          a      b  
Fig. 1. XRD (a) and IR (b) spectra of SBF modified amorphous calcium phosphate. 
The fast precipitation was carried out by mixing Solution 1 and Solution 2 (Table 4) at a 
Ca/P ratio of 1.67 and pH of 11.5 (maintained by 1M KOH) under intense stirring at room 
temperature. It is known that the fast mixing, the high supersaturation and the presence of 
Mg2+ and CO32- ions provoke the precipitation of an amorphous calcium-deficient product 
(Sinyaev et al., 2001; Combes & Rey, 2010). The continuous co-precipitation was carried out 
by mixing Solution 1 and Solution 2 (Table 4) at a rate of 3 ml/min to precipitate in glycine 
buffer (Sykora, 1976) at room temperature and pH 8 (maintained by 1M KOH). 
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Mg 
mmol/g 
Na 
mmol/g 
K 
mmol/g 
Cl 
mmol/g Mg/Ca Ca/P (Ca+Mg+Na+K)/P 
Biomimetic precipitated ACP at quick mixing 
0.13 0.20 0.45 0.03 0.03 1.51 1.79 
Biomimetic precipitated ACP at continuous co-precipitation 
0.04 0.05 0.01 0.05 0.005 1.3 1.33 
Enamel, Dentin, Cementum, Bone (Dorozhkin, 2009) 
0.02 - 0.29 0.22 - 0.39 2.10-4 - 0.02 0.03 – 0.1 0.03 – 0.06 1.61 -1.77  
Table 5. Compositions of ACP precursor and natural Enamel, Dentin, Cementum and Bone. 
Zn- or Mg-modified amorphous calcium phosphate precursors with varying 
Me2+/(Ca2++Me2+) ratio from 0.01 to 0.16 (Table 6) due to Ca2+ ion substitution by Me2+ ions 
as well as Me2+ incorporation were precipitated by the method of continuous co-
precipitation in electrolyte system only. All reagents (Solutions 1, 2 and 4 for Zn-modified 
precursors and Solutions 1 and 3 for Mg-modified precursors, Table 4) with a 
(Ca2++Me2+)/P ratio of 1.67 (Me2+ = Mg, Zn) were mixed to precipitate in glycine buffer with 
a rate of 3 ml/min at room temperature and pH 8 (maintained by 1M KOH). The modified 
conventional simulated body fluids provided ion modification of all Mg- and Zn-modified 
calcium phosphate precursors with Na+ (0.02 - 0.08 mmol/g), K+ (0.01 – 0.02 mmol/g, Mg 2+ 
(0.04 mmol/g) and Cl- (below 0.05 mmol/g) ions (Table 6). 
 
Sample 
Liquid 
phase 
Solid phase 
Me2+/(Me2+
+Ca2+) 
in initial 
solutions 
Me2+/(Me2+
+Ca2+) 
(Ca2++Mg2+
+Zn2++Na+
+ K+)/P 
Zn2+, 
mmol/g 
Mg2+, 
mmol/g 
Na+, 
mmol/g 
K+, 
mmol/g 
Cl-, 
mmol/g 
Zinc-modified calcium phosphates 
Zn1 0.01 0.01 1.31 0.09 0.03 0.03 0.01 <0,05 
Zn3 0.03 0.03 1.35 0.29 0.05 0.04 0.02 <0,05 
Zn5 0.05 0.05 1.35 0.41 0.04 0.05 0.02 <0,05 
Zn10 0.10 0.10 1.31 0.90 0.06 0.02 0.01 <0,05 
Zn13 0.13 0.13 1.40 1.19 0.05 0.08 0.02 <0,05 
Magnesium-modified calcium phosphates 
Mg2 0.03 0.02 1.36 - 0.21 0.05 0.02 <0,05 
Mg5 0.10 0.05 1.35 - 0.45 0.08 0.01 <0,05 
Mg10 0.13 0.10 1.33 - 0.85 0.06 0.02 <0,05 
Mg16 0.20 0.16 1.38 - 1.45 0.04 0.02 <0,05 
Table 6. Ion content of the magnesium- and zinc- modified calcium phosphates and their 
initial solutions. 
By analogy with Bigi et al. (1995), we have established that the presence of Zn2+ or Mg2+ ions 
in the reaction mixture inhibits the crystallization of HA, so that XRD amorphous Mg- or 
Zn-modified calcium phosphate precursors are obtained. The Posner’s clusters (Betts et al., 
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1975; Blumenthal et al., 1977) of the complex formula CawMgxZnyNazKu(PO4)v(CO3)6-v 
(w+x+y+z+u ≤ 9) are the first particles formed in the studied complex electrolyte SBF – 
CaCl2 – MgCl2/ZnCl2 – KOH – H2O system. A modifying ion, whose ionic radius and 
electrical charge are closer to those of the Ca2+ ions, will be more readily incorporated into 
the Pozner’s clusters. The Zn2+ ionic radius (0.74 Å) is closer to that of the Ca2+ ion (1.0 Å) 
than the radius of the Mg2+ ion (0.65 Å). The substitution with Na+ (0.95 Å) and K+ (1.33 Å) 
ions is partial not only for geometrical reasons but also for electrostability. The results (Table 
6) showed that all Zn2+ ions and only about half of the Mg2+ ions from the reaction solutions 
were included in the precipitated ACP. The different chemical behavior of Zn2+ and Mg2+ 
ions can be explained by the “softness-hardness” factor and by the Crystal Field 
Stabilization Energy (CFSE). According to Pearson’s concept of “hard” and “soft” Lewis 
acids and bases (Pearson, 1963), as well as the Klopman scale of hardness and softness 
(Klopman, 1968), “soft acids” predominantly coordinate “soft bases” and “hard acids” - 
predominantly “hard bases”. Mg is a “hard acid”, while Zn is a “soft acid”. The simulated 
body fluids contain high concentrations of Cl- ions which are “softer bases” than H2O, OH-, 
PO43-, SO42-, HCO3- and HPO42-. Although Zn2+ ions are a “soft acid”, they form a negligible 
amount of chloride complexes due to the zero value of their CFSE and mainly exist as free 
Zn2+ ions in the studied solutions. In contrary, Mg2+ as a “hard acid” is preferentially 
coordinated by the H2O molecules (“hard base”) and are mainly present as [Mg(H2O)6]2+ 
complexes. The last ones are too large to be incorporated into the crystal structure of the 
calcium phosphate without its distortion. The necessity of overcoming the energy barrier for 
even partial dehydration of the [Mg(H2O)6]2+ complexes is another reason for the low 
substitution rate of these ions.  
DCPD biomimetic precipitated precursors - Well crystallized dicalcium phosphate 
dihydrate (DCPD) (Fig.2) was precipitated by the method of fast mixing (room temperature 
and intense stirring) of Solution 1 and Solution 5 (Table 4) at a Ca/P ratio of 1 and pH 6 
(maintained by 1M HCl). Differently from all modified ACP precursors, only negligible 
amounts of Mg2+ (0.001 mmol/g), Na+ (0.025 mmol/g), K+ (0.001 mmol/g) and Cl- (0.003 
mmol/g) ions were found in biomimetic precipitated DCPD.  
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Fig. 2. XRD (a) and IR (b) spectra of precipitated DCPD. 
www.intechopen.com
 Biomimetic Modifications of Calcium Orthophosphates 
 
143 
Thermodynamic modeling of biomimetic precipitation - The precipitation processes of 
SBF-modified ACP and DCPD as well as of Zn- and Mg-modified ACP were simulated by 
an ion-association model using the computer program PHREEQCI v.2.14.3 (Parkhurst, 
1995). All possible association/dissociation and dissolution/ crystallization processes in the 
SBFs were taken into account. The formation of complexes and the precipitation of salts 
were considered by means of a mass-action expression using the appropriate formation 
constants or solubility products. The activity coefficients of all possible simple and complex 
species were calculated by the extended Debye-Huckel theory using an updated database 
(Todorov, et al., 2006).  
The saturation indices (SI) (eq. 1), calculated under the experimental conditions were used 
as indicators for possible salt crystallization (Table 7), 
 SI = lg(IAP/K) (1) 
where IAP is an ion activity product and K is a solubility product.  
When the solution is supersaturated with respect to a certain salt (SI > 0), it will precipitate; 
when the solution is undersaturated (SI < 0), the salt will not precipitate; the solution and 
the salt will be in equilibrium when SI = 0. 
Different calcium, magnesium, sodium and potassium salts can simultaneously co-
precipitate in electrolyte SBF systems. Their number depends on the precipitation conditions 
(Table 7). 
In the SBF with pH value of 11.5, nine salts display positive SI, namely Mg(OH)2, 
CaHPO4, Mg3(PO4)2.8H2O, MgCO3.Mg(OH)2.3H2O, CaCO3, Ca3(PO4)2(am), 
Ca8H2(PO4)6.5H2O, Ca9Mg(HPO4)(PO4)6 and Ca10(PO4)6(OH)2 (Table 7) and can co-
precipitate. At pH 8 the same salts including CaHPO4.2H2O but except Mg(OH)2 can co-
precipitate. The increase of the Mg2+ ion concentration in the system leads to co-
precipitation of extra four metastable magnesium salts and favors the precipitation of 
Ca9Mg(HPO4)(PO4)6 (SI increases). The increase of the Zn2+ concentration in the system 
does not influence the co-precipitated salts. The only zinc phosphate salt Zn3(PO4)2.4H2O 
is not expected to precipitate (SI<0). In SBF of pH 6 where DCPD precipitates, only 
calcium phosphate salts can co-precipitate. In all cases, the highest SI and the highest 
thermodynamic stability are displayed by Ca10(PO4)6(OH)2 followed by 
Ca9Mg(HPO4)(PO4)6. Despite the thermodynamic stability of HA, the kinetic factors favor 
the formation of metastable phases – ACP at pH 8 and 11.5 and initial (Ca+Me)/P = 1.67 
and DCPD at pH 6 and Ca/P = 1. These results are in compliance with Ostwald’s step 
rule, according to which the crystal phase that nucleates is not the phase that is most 
thermodynamically stable under these conditions, but rather is a metastable phase closest 
in free energy to the parent phase (Chung, et al., 2009). The highest crystallization rate 
and the lowest supersaturation necessary for nucleation should be exhibited by those salts 
in the saturated solution, for which there is a sufficient concentration of structural entities 
able to be incorporated unchanged or with small changes into the crystal structure. 
5. Biomimetic modifications and phase transformations of ACP and DCPD 
With the aim to elucidate the influence of micro-environmental surroundings on the phase 
transformation process of SBF-modified ACP, DCPD, and Zn-modified ACP we have 
investigated their biomimetic maturation in SBFs by  means of kinetic, spectral and 
thermodynamic studies. The experiments were performed with three different SBFs – 
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Solid phases 
SBF modified 
ACP 
Mg 
modified 
ACP 
Zn 
modified 
ACP 
SBF 
modified 
DCPD 
pH 11.5 pH 8 pH 8 pH 8 pH 6 
NaCl -3.13 -3.18 -3.14 -3.21 -3.29 
NaHCO3 -5.75 -3.30 -3.31 -3.24 -3.69 
Na2CO3.H2O -6.78 -7.85 -7.82 -7.77 -10.17 
Na2CO3.10H2O -4.9 -5.97 -5.94 -5.87 -8.80 
NaHCO3.Na2CO3.2H2O -11.65 -10.27 -10.25 -10.13 -12.44 
Na2SO4 -6.81 -6.80 -6.82 -6.70 -6.70 
Na2SO4.10H2O -5.45 -5.44 -5.46 -5.33 -5.92 
KMgPO4:6H2O -0.32 -0.76 0.60 -1.11 -3.32 
Mg(OH)2 0.11 -6.63 -5.18 -6.47 -10.95 
MgCO3 -0.73 -1.50 -0.11 -1.32 -3.98 
MgCO3.3H2O -3.54 -4.31 -2.92 -4.13 -6.49 
Mg5(CO3)4(OH)2.4H2O -5.12 -14.94 -7.91 -14.07 -27.17 
MgCO3.Mg(OH)2.3H2O 1.09 -6.42 -3.57 -6.08 -12.29 
MgSO4.7H2O -6.47 -6.16 -4.81 -5.96 -6.13 
MgHPO4.3H2O -3.49 -0.38 0.95 -0.60 -0.76 
Mg3(PO4)2 -1.08 -1.60 2.5 -1.90 -6.72 
Mg3(PO4)2.8H2O 0.78 0.27 4.36 -0.03 -4.86 
Mg3(PO4)2.22H2O -1.23 -1.74 2.35 -2.02 -6.85 
Ca(OH)2 -1.39 -8.52 -8.45 -8.54 -12.06 
CaCO3 2.62 1.45 1.46 1.46 -0.87 
CaSO4 -1.67 -1.76 -1.80 -1.74 -1.67 
CaSO4.2H2O -1.44 -1.53 -1.56 -1.50 -1.49 
CaHPO4 0.14 2.86 2.86 2.86 2.20 
CaHPO4.2H2O -0.15 2.56 2.51 2.17 1.96 
Ca3(PO4)2(am) 8.37 6.66 6.62 5.85 1.35 
Ca8H2(PO4)6.5H2O 26.63 28.64 28.45 26.24 17.14 
Ca9Mg(HPO4)(PO4)6 34.19 32.19 33.39 29.54 15.88 
Ca10(PO4)6(OH)2 60.18 47.92 47.87 45.49 28.35 
Zn(OH)2    -6.44  
ZnCO3    -5.35  
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ZnCO3.H2O    -5.10  
Zn2(OH)3Cl    -12.28  
ZnSO4.H2O    -13.98  
ZnSO4.6H2O    -12.88  
ZnSO4.7H2O    -12.64  
Zn2(OH)2SO4    -16.36  
Zn3(PO4)2.4H2O    -9.49  
Table 7. Saturation indices (SI) of solid phases in the studied systems. 
conventional, SBFc, revised, SBFr, and conventional modified with glycine, SBFg (Table 3). 
Before maturation the precipitated precursors were filtered, washed with water and with 
acetone (solid-to-liquid ratio of 1:1) and lyophilized at -56oC. Then the freeze-dried samples 
were matured for varying time periods (from 1 h to 6 months) at a solid-to-liquid ratio of 
1:250, physiological temperature of 37oC, in a static regime. 
The biomimetic modification of SBF-modified ACP in SBFc, SBFr and SBFg gave rise to 
changes in the compositions of both solid and liquid phases during the maturation process 
(Fig. 3) and revealed that dissolution/crystallization processes are strongly influenced by 
the content of SBFs.  
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Fig. 3. Kinetic profiles of PO43- (a), Ca2+ (b) and Mg2+ (c) in liquid and solid (d, e) phases. 
A similar behavior of PO43- (Fig. 3a), Ca2+ (Fig. 3b), and Mg2+ (Fig. 3c) ions was found in the 
three SBFs. The biggest changes were registered during the first 6 hours. The liquid phases 
were enriched in Ca2+, Mg2+, and PO43- ions during the first 2 - 4 h; afterwards, until the 6th 
hour, the enrichment rate gradually decreased. The highest increase was registered for Ca2+ 
(32%) and Mg2+ (46%) ions in SBFg. Their highest decrease was observed in SBFr. For Ca2+ 
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ions this decrease was about 90% for 6 hours, while for Mg2+ ions the decrease continued 
after the 6th hour and reached 83% at the 72nd hour. The presence of glycine in SBFg and the 
higher content of HCO3- ions in SBFr leads to formation of metal-glycine and metal-
carbonate complexes that enhance the solubility of the salts. During maturation in SBFr 
which is richer in HCO3-, crystallization of CaCO3 occurs, also confirmed by the increased 
Ca/P ratios in the solid phase (Fig.3d), whereas in SBFc and SBFg the formation of calcium 
phosphate dominates. The increase of the Mg/Ca ratio in the solid phases (Fig.3e) gives an 
evidence for the incorporation of Mg2+ in the amorphous phase. 
The spectral studies (XRD and IR) confirmed the biomimetic phase transformation of 
amorphous calcium phosphate into the more stable poorly-crystalline apatite in the three 
SBFs, differing only in the phase transformation rate (Fig 4). Crystal phase was detected at 
the 4th hour of the maturation process in SBFc; at the 2nd hour in SBFr and at the 1st hour in 
SBFg (Fig 4a). The increase in the degree of crystallinity during the maturation process was 
confirmed by the observed splitting of the phosphate bands at 960, 1100, 562, and 603 cm-1, 
which are characteristic for the IR spectra of crystalline calcium phosphate (Fig 4b). 
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Fig. 4. XRD patterns (a) and IR (b) spectra for different SBFs and maturation times. 
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IR data also revealed a change in the carbonate content of the samples treated in SBFc and 
SBFr with different carbonate content (Fig. 5). As a measure of the carbonate content we 
used the ratio between the areas underneath the peaks corresponding to CO32- (1549-1336 
cm-1) and PO43- (1280-914 cm-1) stretching bands. As can be seen, the amount of carbonate 
ions faster increases in samples matured in SBFr than in those matured in SBFc. 
Thermodynamic modeling of the maturation process of two different solid calcium 
phosphate products - a metastable amorphous product (*ACP), and a stable equilibrium 
product (**ACP) were done in the three solutions (SBFc, SBFr and SBFg) differing in their 
ionic content (Table 8).  
 
Phase 
Maturation of *ACP Maturation of **ACP 
SBFc SBFr SBFcg SBFc SBFr SBFcg 
NaCl -3.59 -3.66 -3.59 -3.59 -3.65 -3.59 
Na2SO4 -6.15 -6.14 -6.16 -6.14 -6.13 -6.14 
Na2SO4.10H2O -5.34 -5.32 -5.35 -5.33 -5.31 -5.33 
NaHCO3 -3.53 -3.17 -3.59 -3.81 -2.4 -3.54 
NaHCO3.Na2CO3.2H2O -9.76 -8.69 -9.94 -12.95 -9.05 -12.04 
Na2CO3.H2O -7.66 -6.94 -7.78 -10.56 -8.08 -9.93 
Na2CO3.10H2O -6.25 -5.53 -6.37 -9.15 -6.67 -8.53 
MgSO4.7H2O -5.26 -5.84 -5.33 -5.25 -5.25 -5.22 
MgCO3 -1.17 -1.05 -1.34 -4.07 -1.6 -3.40 
MgCO3.3H2O -3.67 -3.55 -3.84 -6.56 -4.1 -5.90 
Mg3(PO4)2 -2.27 -1.90 -2.78 -9.29 -5.77 -8.00 
MgHPO4.3H2O -1.01 -0.89 -1.19 -1.91 -1.21 -1.64 
Mg3(PO4)2.22H2O -2.3 -1.93 -2.83 -9.32 -5.8 -8.06 
Mg5(CO3)4(OH)2.4H2O -10.95 -10.33 -11.80 -27.75 -15.76 -24.36 
KMgPO4.6H2O -2.92 -2.43 -3.25 -6.43 -4.66 -5.91 
Ca(OH)2 -9.01 -9.01 -9.01 -14.34 -13.49 -14.06 
CaSO4 -2.77 -3.48 -2.66 -2.86 -4.13 -3.29 
CaSO4.2H2O -2.58 -3.28 -2.48 -2.67 -3.94 -3.10 
CaMg3(CO3)4 -3.18 -2.81 -3.69 -14.86 -6.25 -12.67 
CaHPO4.2H2O -0.23 -0.23 -0.23 -1.23 -1.8 -1.42 
Mg(OH)2 -5.95 -5.93 -6.16 -11.05 -9.0 -10.47 
Mg3(PO4)2.8H2O -0.37 0 -0.89 -7.14 -3.77 -6.16 
MgCO3.Mg(OH)2.3H2O -4.41 -4.27 -4.83 -12.29 -7.75 -11.12 
CaCO3 0 0 0 -2.94 -1.77 -2.80 
CaHPO4 0 0 0 -1.05 -1.61 -1.11 
Ca3(PO4)2(am) 0 -0.10 0 -6.76 -7.64 -7.43 
Ca8H2(PO4)6.5H2O    -6.62 -8.43 -7.19 
Ca9Mg(HPO4)(PO4)6    -11.37 -11.55 -11.36 
Ca10(PO4)6(OH)2    0 0 0 
Notes: The impurities in the washed initial products were taken in the range 1-3 % based on the 
measured Mg/Ca ratio (3 mol %) (Table 5). 
*ACP – metastable amorphous product; **ACP – stable equilibrium product. 
Table 8. Likely salts in the biomimetic systems and their thermodynamic calculated 
saturated indices (SI) at biomimetic maturation. 
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Fig. 5. Changes in the carbonate content of the samples treated in SBFc and SBFr.   
The metastable amorphous product (*ACP) simulated the system behavior during the first 
1-2 hours of maturation, when no Ca8H2(PO4)6.5H2O, Ca9Mg(HPO4)(PO4)6 and 
Ca10(PO4)6(OH)2 phase was yet formed, whereas the stable product (**ACP) simulated the 
equilibrium system. The maturation of the metastable amorphous product (*ACP) leads to a 
phase transformation that depends on the content of HCO3- ions in SBF at the beginning of 
the process (Table 8). In a solution with a low HCO3- content (SBFc and SBFg), dissolution 
phenomena of all magnesium salts occur (SI<0) during maturation and the system will be in 
equilibrium with the calcium salts (SI = 0), including the amorphous calcium phosphate. 
The increase in the HCO3- content (SBFr) leads to dissolution and phase transformation of 
the amorphous calcium phosphate into thermodynamically more stable salts. The calculated 
equilibrium amounts of CaCO3 and Ca3(PO4)2(am) in the three investigated body fluids (Fig. 
6) point to the significantly favored crystallization of CaCO3 (especially in SBFr) and the 
decreased amount of Ca3(PO4)2(am) due to dissolution processes. The calculations revealed 
that there was no influence of SBFs composition on the equilibrium product (**ACP), the 
system tending to thermodynamic equilibrium by dissolution of all co-precipitated solid 
phases and re-crystallization of the thermodynamically unstable amorphous calcium 
phosphate (with SI<0) into pure HA (with SI = 0) (Table 8). 
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Fig. 6. Calculated equilibrium amounts of CaCO3 and Ca2(PO4)3(am). 
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The model cannot predict the formation of Mg-substituted carbonated hydroxyapatite due 
to the lack of thermodynamic data. 
The calculated species distribution in the initial SBFs, in the SBFs at metastable (maturation 
of *ACP) and at stable (maturation of **ACP) equilibrium (Fig. 7) gives an evidence for the 
domination of Me2+ (Me = Ca, Mg) free ions in all studied cases. In the initial SBFs (Fg. 7a 
and 7b) and at a stable thermodynamic equilibrium (Fig. 7e and 7f) Me2+ free ions are 
dominating, followed by MeCl+ in SBFc, from MeHCO3- and MeCl+ in SBFr and from 
CaH(Gly)2+ and CaCl+ and from MgCl+ and Mg(Gly)+ in SBFg. Significant changes in species 
distribution are observed at a metastable equilibrium (Fig. 7c and 7d), revealing the essential 
role of SBF ionic composition on the maturation process. The increased amount of MeHPO42-, 
CaPO4- in SBFc and SBFr, as well as the increased amount of Me(Gly)+ species in SBFg is due 
to the dissolution of metastable salts while the decreased amount of MeHCO3- species 
especially in SBFr is due to the crystallization of CaCO3.  
These thermodynamic data explain the results from the maturation kinetics.  
The biomimetic modifications of Zn-modified ACP were studied on three exemplary 
samples with different Zn2+/(Zn2+ + Ca2+) molar ratios (0.03, 0.05 and 0.10), treated in a 
conventional simulated body fluid (SBFc). It was found that the Zn content decreases by a 
factor of 2 during the first 2 hours (Fig. 8) when the samples are still amorphous (Fig. 9). 
Subsequently, the amorphous phase progressively converted into poorly-crystalline apatite. 
The Zn content influenced the transformation rate. At a higher Zn content the stability of the 
amorphous phase increased and the rate of the process slowed down (Fig. 9). 
The kinetic studies of the biomimetic modifications of DCPD revealed that the 
compositions of the liquid and solid phases, similar to those of ACP, changed during the 
maturation process (Fig. 10). In SBFg the highest increase in PO43- and Ca2+ concentrations 
was registered   as  a  result  of  the effect of glycine which promotes the dissolution of 
DCPD. In the solid phase the Ca/PO4 ratio is kept ≈1 during the first 6 hours, then gradually 
increases. The latter is an indication for the beginning of the transformation process and the 
formation of basic calcium phosphates with Ca/PO4 > 1.  
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Fig. 7. Ca and Mg species distribution in initial SBF (a and b); at maturation of *ACP (c and 
d); at maturation of **ACP (e and f)  
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Fig. 9. XRD patterns of solid phases with Zn2+/(Zn2+ + Ca2+) ratios of 0.03 (a); 0.05 (b) and 
0.1 (c) matured for different times in SBFc. 
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Fig. 10. Kinetic profiles of pH (a), PO43- (b), Ca2+ (c), in the liquid phases and of the Ca/PO4 
ratio in the solid phases (d) during maturation. 
www.intechopen.com
 Biomimetic Modifications of Calcium Orthophosphates 
 
153 
IR and XRD data (Fig.11) show that the initial DCPD transforms into poorly-crystalline B-
type carbonate apatite via an intermediate phase of OCP. The rate of conversion of DCPD to 
carbonated apatite differs, depending on the type of SBF. The formation of carbonated 
apatite is faster in SBFr, as it is indicated by the disappearance of O-H and P-OH peaks 
typical of DCPD phase and the appearance of absorption bands near 1420 and 1480 cm-1 
associated with B-type CO32- groups after 240 h of treatment (Rabadjieva et al., 2010). For 
samples treated  in  SBFc  DCPD  phase  is  still preserved after 72 h of treatment, while the 
carbonate peaks appeared after 720h (one month) maturation and increased in intensity 
after 6 months, indicating slow rate of PO43− substitution by CO32- groups.  Intense 
absorption bands in the 1073-1122 cm-1 spectral range are due to the asymmetric stretching 
vibration mode of P-O, whereas the absorption band that appears near 963 cm-1 is associated 
with the symmetric stretching mode of P-O. Peaks at 602, 562 and at 470 cm-1 originate from 
O-P-O bending modes. O-H stretching bands of crystalline water appeared in the range of 
3500-3100 cm-1, while H2O bending is at 1640-1650 cm-1. Peaks at 1297 and 1192 cm-1 are due 
to the P-OH bending mode of HPO42- groups, while those near 914 and 870 cm-1 arise from 
the stretching mode of HPO42- groups and partially overlapped with C-O vibrations. The 
absorption bands at around 878 cm-1 could be due to bending vibration of CO32- groups, 
because are related with intensive bands in the 1400-1500 cm-1 spectral interval, typical of C-
O stretching vibrations. Peak at 526 cm-1 is associated with HO–PO3 bending mode in 
HPO42- (Mendel & Tas, 2010; LeGeros et al., 1989). 
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Fig. 11. IR spectra (a) and XRD patterns (b) at different maturation time. 
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6. High-temperature phase transformations of ion modified ACP 
The matured Zn- and Mg-modified ACP precursors were treated by a procedure including 
gelation with Xanthan gum, lyophilization at -56oC, washing (solid-to-water ratio of 1:100) 
and secondary lyophilization. Then they were sintered at 600, 800 and 1000оС in order to 
study the high-temperature phase transformations and to follow the effect of Mg2+ and Zn2+ 
on the Ca2+ ion substitution and on the phase composition and morphology of the sintered 
products. The working regime consisted of heating at a rate of 3oC/min up to the desired 
temperature and keeping it constant for 1 hour. Both, concentration of Mg2+ and Zn2+ ions 
and temperature affect the spectral characteristics of the studied samples (Fig. 12). The 
hydroxyl stretching peaks near 3570 cm-1 and the hydroxyl librations at 633 cm-1 revealed 
the presence of HA phase, while the peaks near 1120, 1075, 1040, 975 and 950 cm-1 indicated 
the formation of ǃ-TCP phase.  
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Fig. 12. FT IR spectra of Zn-modified (a) and Mg-modified (b) calcium phosphates at 
different temperatures. 
The XRD data (Fig. 13) revealed that all amorphous precursors were transformed into ion-
modified HA or ǃ-TCP crystalline phases depending on the additive and its amount as well 
as on the temperature. Both Zn and Mg substitutions promoted the ACP transformation to 
ion-modified HA and ǃ-TCP but the effect was more pronounced in the case of Zn 
substitution. Zn-ǃ-TCP and Mg-ǃ-TCP were registered at 600oC for samples with 
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Me2+/(Me2+ + Ca2+) ratios higher than 0.05 and mixture of the ion-modified HA and -TCP 
calcium phosphates at ratios lower than 0.05. The SEM analyses revealed that Zn and Mg 
substitutions influenced the morphology of the ǃ-TCP grains (Fig 14). Sintering at 800-
1000oC leads to zinc-modified-ǃ-TCP powders of idiomorphic crystals with sizes ranging 
from 500 to 5000 nm in all studied cases. Magnesium-modified-ǃ-TCP fine powders with 
spherical grains of smaller size (250 - 1000 nm) were obtained at a Mg2+/(Mg2+ + Ca2+) ratio 
higher than 0.02 (Figure 13 and 14). The surface of the spherical grains of magnesium 
modified samples was covered by blanket, while clean grain boundary was observed in the 
zinc-modified samples. 
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Fig. 13. XRD powder data of Zn-modified (a) and  Mg-modified (b) calcium phosphates at 
different temperatures. (▄ - HAP; not marked – Me2+-ǃ-TCP). 
The calculated unit cell parameters showed that low ion substitution (Me2+/(Me2++Ca2+) 
ratio up to 0.05) leads to a slight decrease in the parameter a and the volume V and to an 
increase in the parameter c of the Me-ǃ-TCP unit cell (Table 9). This tendency became more 
pronounced at higher temperatures. 
The inclusion of Mg2+ and Zn2+ ions into the crystal unit cell of the thermodynamically 
stable HA proceeds through Ca2+ ion substitution. As the ionic radii of Mg2+ (0.65 Å) and  
 
www.intechopen.com
 On Biomimetics 
 
156 
Sample 
600oC 800oC 1000oC 
a, Å c, Å V, Å3 a, Å c, Å V, Å3 a, Å c, Å V, Å3 
Zinc-modified calcium phosphates 
Zn1 * * * 10.423 37.339 3513 10.417 37.393 3514 
Zn3 * * * 10.437 37.101 3500 10.390 37.142 3471 
Zn5 * * * 10.397 37.062 3469 10.387 37.042 3460 
Zn10 10.345 36.902 3420 10.329 36.903 3410 10.349 37.153 3446 
Zn13 10.332 37.005 3421 10.349 36.988 3431 10.339 37.227 3446 
Magnesium-modified calcium phosphates 
Mg2 * * * 10.420 37.278 3505 10.415 37.301 3504 
Mg5 10.419 37.314 3508 10.403 37.324 3498 10.393 37.319 3491 
Mg10 10.356 37.161 3452 10.368 37.234 3466 10.346 37.134 3442 
Mg16 10.332 37.152 3435 10.340 37.213 3446 10.391 37.28 3486 
* poorly crystallized phase. 
Table 9. Unit cell parameters of Me2+-modified calcium phosphates. 
Zn2+ (0.74 Å) are too small in comparison with that of Ca2+ (1.00 Å) the increase in their 
amount leads to unit cell distortion and volume decrease, established also by Ito et al. (2002) 
and Miyaji et al. (2005). Thus, the structure  of Me2+ ion modified HA is destabilized and  
 
       
  a     b   
 
        
  c     d   
Fig. 14. SEM images of Me2+-modified calcium phosphates heated at 1000oC:  
a) Mg2+/(Mg2++Ca2+) = 0.02; b) Mg2+/(Mg2++Ca2+) = 0.10; c) Zn2+/(Zn2++Ca2+) = 0.01;  
d) Zn2+/(Zn2++Ca2+) = 0.13. 
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its transformation into the more stable ǃ-TCP structure could be expected. The latter 
structure includes different CaOn coordination polyhedra (n=3,6,7,8) (Yashima et al., 2003). 
The vacant sites of the smallest CaO3 polyhedron are the most suitable holes for the 
inclusion of the small Mg2+ and Zn2+ ions, thus the unit cell distortion and structure 
destabilization will be negligible. Ion substitution at a Me2+/(Ca2++Me2+) ratio higher than 
0.05-0.15 leads to an increase in the Me2+ ion inclusion into the larger CaOn polyhedra (n=6-
8), which destabilizes the structure. The appearance of a more stable high-temperature 
modification, ǂ-TCP, could be expected in this case, but no ǂ-TCP XRD peaks were detected 
in our experiments.  
7. Conclusions 
In a summary, original authors’ studies and literature data are presented on the biomimetic 
synthesis of XRD-amorphous calcium phosphate and dicalcium phosphate dihydrate and 
their biomimetic modifications and phase transformations into poorly-crystalline apatite in 
three types of simulated body fluids - conventional (SBFc), revised (SBFr) and modified with 
glycine (SBFg). The compositions of the different types of artificial body fluids that are 
known in the literature are compared in terms of their similarity to blood plasma; their 
advantages and disadvantages are highlighted. The authors’ studies and original results on 
chemical and phase compositions, kinetics and thermodynamic simulations are discussed. A 
new approach based on thermodynamic modeling (using the PHREEQCI v.2.14.3 computer 
program based on an ion-association model) was applied for simulation and explanation of 
the biomimetic precipitation of metastable XRD-amorphous calcium phosphate and 
dicalcium phosphate dihydrate instead of the thermodynamically stable hydroxyapatite and 
of their biomimetic phase transformations during the maturation processes. The crucial role 
of the SBF as an electrolyte system is emphasized. 
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